egfr tkis for upfront treatment of nsclc
Published 8 years ago • 707 plays • Length 5:47Download video MP4
Download video MP3
Similar videos
-
1:52
dr. clarke on available egfr tkis in frontline treatment of egfr nsclc
-
20:24
targeted treatment with egfr tkis: front line options
-
4:41
upfront egfr-targeted therapy for nsclc
-
5:00
options for up-front therapy in egfr-mutant nsclc
-
1:24
egfr tkis excite treatment landscape of egfr-mutant lung cancers
-
5:45
egfr tki sequencing
-
1:42
dr. bazhenova on sequential use of immunotherapy and egfr tkis in lung cancer
-
2:45
activity of egfr tkis in patients with nsclc with uncommon egfr mutations
-
4:38
egfr tkis as adjuvant therapy in nsclc
-
6:03
managing resistance to egfr tkis in nsclc
-
5:01
chemotherapy-tki combinations in metastatic egfr lung cancer
-
5:52
treatment of egfr nsclc after osimertinib
-
6:53
upfront use of second-generation tkis in alk nsclc
-
5:02
addition of bevacizumab to up-front therapy for egfr nsclc
-
3:48
mechanisms of resistance to upfront egfr-targeted therapy
-
1:27
dr. wakelee discusses egfr tkis in lung cancer
-
3:12
egfr-tki therapy in advanced nsclc
-
16:30
up-front treatment in egfr wild-type patients
-
2:41
egfr tkis in the adjuvant setting in nsclc